AbbVie Contract Manufacturing AbbVie Contract Manufacturing

X

Find the latest Drugs in Development and Pipeline Prospector News of Quest Products.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Quest Products
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
8201, 04th stree, suite 200, Pleasant Prairie, WI 53158
Telephone
Telephone
800.650.0113
Linkedin
Linkedin

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

left grey arrow
right gray arrow

Details:

Funds support continued patient enrolment into the Ri-CoDIFy Phase 3 clinical trial program of ridinilazole for the treatment of Clostridium difficile infection; launch of Ridinilazole and Development of early-stage research projects using the Company’s Discuva Platform.


Lead Product(s): Ridinilazole

Therapeutic Area: Infections and Infectious Diseases Product Name: Undisclosed

Highest Development Status: Phase IIIProduct Type: Small molecule

Partner/Sponsor/Collaborator: Undisclosed

Deal Size: $50.0 million Upfront Cash: Undisclosed

Deal Type: Financing October 02, 2020

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

Quest will add the Enemeez and DocuSol brands of bowel care products, to its' portfolio of self-care products.


Lead Product(s): Docusate Potassium

Therapeutic Area: Gastroenterology Product Name: Enemeez

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Quest Products, LLC

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Acquisition June 24, 2020

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY